Actinomycotic infection of the oesophagus

Abdalla, Jehad; Myers, James W.; Moorman, Jonathan P.

doi:10.1016/j.jinf.2004.08.011

Cited by 58 publications

(16 citation statements)

References 12 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other locations for actinomycotic lesions categorized as cervicofacial actinomycosis include, for instance, the nasal and sinus region (70)(71)(72); pharynx (73,74); larynx/tonsillae (75-78); middle ear, mastoid, and/or temporal bone (79)(80)(81); and skull base with the craniovertebral junction (82). A somewhat more distant location is the esophagus, from where actinomycotic lesions have also been recovered in both immunocompetent and immunocompromised individuals (83,84). Except for actinomycotic cases with A. meyeri in the middle ear and mastoid (79) and A. israelii in the mastoid (81) and in the skull base (82), identified by molecular methods, as well as A. odontolyticus in the larynx (77), diagnoses were not based on microbiology but on clinical manifestations and histopathology with or without a presentation of sulfur granules.…”

Section: Orocervicofacial Actinomycosismentioning

confidence: 99%

Actinomyces and Related Organisms in Human Infections

2015

View full text Add to dashboard Cite

SUMMARY Actinomyces israelii has long been recognized as a causative agent of actinomycosis. During the past 3 decades, a large number of novel Actinomyces species have been described. Their detection and identification in clinical microbiology laboratories and recognition as pathogens in clinical settings can be challenging. With the introduction of advanced molecular methods, knowledge about their clinical relevance is gradually increasing, and the spectrum of diseases associated with Actinomyces and Actinomyces -like organisms is widening accordingly; for example, Actinomyces meyeri , Actinomyces neuii , and Actinomyces turicensis as well as Actinotignum (formerly Actinobaculum ) schaalii are emerging as important causes of specific infections at various body sites. In the present review, we have gathered this information to provide a comprehensive and microbiologically consistent overview of the significance of Actinomyces and some closely related taxa in human infections.

show abstract

Section: Orocervicofacial Actinomycosismentioning

confidence: 99%

Actinomyces and Related Organisms in Human Infections

2015

View full text Add to dashboard Cite

show abstract

“…Considering the data in the literature on successful therapy of actinomycosis with ceftriaxone this drug may be a good candidate for outpatient approach because it can be administered intramuscularly once in a day. Among the few case reports are thoracic [10,11], oesophageal [12], cerebral [13] and urinary bladder [14] actinomycotic infections in which ceftriaxone was used alone, following surgery or IV penicillin therapy. In the first of our cases we used ceftriaxone following only two weeks of IV sulbactam/ampicillin.…”

Section: Discussionmentioning

confidence: 99%

Successful outpatient management of pelvic actinomycosis by ceftriaxone: a report of three cases

Önal¹,

Altınbaş²,

Önal³

et al. 2009

Braz J Infect Dis

View full text Add to dashboard Cite

Pelvic actinomycosis is a chronic granulomatous suppurative disease caused by actinomyces israeli. Intravenous penicillin is the preferred antimicrobial but it requires hospitalization up to one month. An outpatient treatment strategy would be cost effective and a good choice for patients. Here we present three cases in which intramuscular ceftriaxone was successfully used in the outpatient settings following surgery and IV penicillin treatment in the hospital.

show abstract

“…En la revisión de la literatura efectuada por nosotros se han encontrado 16 casos (1,3). De estos, la mayoría eran pacientes infectados pon el VIH (7 casos) o bien padecían un proceso neoplásico por el que estaban recibiendo quimioterapia o inmu- nosupresores.…”

Section: Discussionunclassified

“…La actinomicosis esofágica es muy infrecuente, habiéndose descrito hasta la actualidad pocos casos. Muchos de ellos eran pacientes inmunodeprimidos o con procesos neoplásicos (1).…”

unclassified